IMM 1.69% 30.0¢ immutep limited

An obsevation re Eftiligomab alfa

  1. 25,334 Posts.
    lightbulb Created with Sketch. 1375
    We are getting near the pointy end of research into Efti's effectiveness in assisting treatment for various cancer indications....
    In combination with keytruda it is showing better results with more successful outcomes for patients than keytruda alone
    in trials conducted sofar....Even signs of a combo that can negate the need for chemotherapy in certrain cases....
    To be brutally honest, there is gonna need to be a major reversal in trial data over the next few months for Efti to fall over...
    We have much to look forward to here and to be honest once again there is cause for confidence...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.005(1.69%)
Mkt cap ! $435.7M
Open High Low Value Volume
30.0¢ 30.5¢ 29.5¢ $598.4K 2.003M

Buyers (Bids)

No. Vol. Price($)
12 192353 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 126073 7
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.